The Effect and Properties of CBG (Cannabigerol) CBG (cannabigerol) is one of more than 100 cannabinoids found in marijuana, however it is considered a minor cannabinoid because it is present at very low quantities in most types (usually between 0.1 and 0.5%). However, because to its growing importance in recent years, it is now one of the substances with the highest potential for medicinal therapies based on this plant.
Despite its therapeutic potential, the difficulties in generating significant amounts of CBG has impeded its research and commercialization. CBG Isolate Bulk extraction is exceedingly expensive due to the large amount of biomass required and the usage of highly specialised equipment, which is why it has been dubbed the "Rolls Royce of cannabinoids." In reality, CBG prices are five times, if not more, than CBD prices. However, this has lately altered due to the introduction of novel genetics rich in CBG, which has made it possible to get it more effectively, hence opening the way to large-scale legal manufacturing. CBG, on the other hand, has a significantly longer history: it was discovered in 1964 by Israeli chemist Raphael Mechoulam and his colleague Yechiel Gaoni at the Hebrew University of Jerusalem while exploring the pathways of cannabinoid production in cannabis. They needed to
find out where all those substances in the plant that interact with our endocannabinoid system came from. They quickly worked it out, discovering the missing link that allows many cannabinoids produced from enzymatic processes to start their lives as CBGA.
How is CBG Created? Cannabigerolic acid (CBGA) is produced by fresh cannabis plants and is the precursor of the three major cannabinoids: tetrahydrocannabinolic acid (THCA), cannabidiolic acid (CBDA), and cannabichromenic acid (CBCA). In fact, this acid is referred to as "the mother of all cannabinoids" because, as the cannabis plant matures, special enzymes in the plant break down CBGA and "guide" it to one of these three lines. When acidic cannabinoids are exposed to light or heat, they undergo a process known as decarboxylation and change into THC, CBD, and other minority cannabinoids. As a result, CBGA almost vanishes because it is merely a passing through; in most strains, CBGA is promptly transformed into THCA or CBDA. Because of the way these molecules are generated, more THC equals less CBG Isolate Bulk and CBD (and vice versa).
What are the Characteristics of CBG? CBG has a partial affinity for the endocannabinoid system's CB1 and CB2 receptors, as does THC, which also produces psychoactive effects through interactions with these receptors, but CBG has been observed to act as a mitigator of this psychoactivity, and may even alleviate the feelings of anxiety or paranoia that can accompany high levels of THC consumption. CBG Isolate Bulk can also stimulate other receptors via other mechanisms. In fact, it has shown a strong potential to enhance anandamide, also known as "the happy molecule," an endogenous cannabinoid that helps control a variety of biological functions such as appetite, sleep, mood, and the immune system. CBG research is still in its early stages, but available studies indicate that it has significant therapeutic promise and could be the next major player in cannabis medicines following the CBD explosion. Its analgesic capabilities may outperform THC without the euphoric impact, and there is evidence that CBG may have anti-cancer and anti-bacterial activities. Indeed, scientists are encouraged by the preliminary findings on CBG and are encouraging continued research for the treatment of a variety of ailments. Because it is non-psychoactive, CBG has a wide range of possible applications, including use as a pain reliever, in psoriasis therapy, and even as an antidepressant. However, researchers have yet to determine the safety and potential long-term negative effects of CBG products, as well as the possibility of drug interactions, owing to a paucity of CBG products for investigation.
What distinguishes CBG from CBD? Preclinical research suggests that CBG and CBD may have many therapeutic properties. However, as previously stated, CBG Isolate Bulk aids in the production of CBD. As a result, while both are cannabinoids, they are distinct substances within the cannabis plant. Despite a
possible pharmacological overlap, they can assist treat distinct ailments since they serve different goals. As an example:
THC's effects are being reduced. Both CBG and CBD are currently regarded non-psychoactive, which means they will not alter your mental state in such a way that it interferes with your daily functioning or mental clarity. This suggests that taking cannabis with a high concentration of CBD and CBG, or drinking a CBG isolate in addition to consuming (smoking or eating) cannabis, may be able to offset the "high" or intoxication caused by THC. CBG is naturally present in the cannabis you are already consuming, but probably not in sufficient quantities to make a difference.
Pharmacology CBD and CBG both activate receptors in various ways. A 2011 study published in Psychopharmacology, for example, evaluated the effects of CBD and CBG on the serotonin 5-HT1A receptor. CBD appears to exert its anti-nausea benefits via acting as an agonist on the 5-HT1A receptor (activator). CBG Isolate Bulk, on the other hand, acts as a 5-HT1A receptor antagonist (blocker). The findings revealed that pretreatment with CBG Oil Wholesale inhibited CBD's antiemetic effects, implying that the two cannabinoids bind to the same location but had opposing effects on this receptor. Another significant difference between CBG and CBD is appetite stimulation. CBG doses stimulated rats to eat more than double their average food consumption, according to research. Cannabigerol had no effect on feeding behaviour in another trial, whereas cannabidiol dramatically reduced total food intake. Furthermore, CBG differs from another phytocannabinoid, THCV, which similarly suppresses hunger and can contribute to weight reduction.
It may also help to lessen inflammation caused by inflammatory bowel disease. According to a 2013 mouse research. Another study published in 2014 discovered that it can even slow the growth of cancer cells and other tumours in rats with colon cancer. Meanwhile, additional studies have found that the chemical may be useful in the treatment of glaucoma, bladder dysfunction, Huntington's disease, and bacterial infections.
How does CBG come into being? While CBD and THC can account for up to 20% of the plant's composition by weight, CBG is almost non-existent in well-matured cannabis flowers, accounting for less than 1%. This means that producers will require 20 times the biomass to produce the same amount of CBG as a typical CBD or THC output. Growers can harvest their plants a little earlier than usual to improve CBG yield while preventing CBGA breakdown from light and heat, but they won't obtain much more (as low as 1% to 3%). However, harvesting plants prematurely to justify extracting a reasonable amount of CBG
sacrifices other potential components, therefore most producers are hesitant to harvest their plants so early and forego other cannabinoids in favour of such a small amount of CBG. Seed bank breeders have to experiment with genetic selection to boost CBG concentration in order to produce larger yields. They have also effectively determined the ideal extraction window in order to conserve the highest levels of CBG, which they propose about six weeks into an eight-week flowering cycle.
Bona Voluntate Pure CBG This is where seed banks like Bona Voluntate come in, as we have been able to present on the market, coinciding with the Spannabis 2022 celebration, a Pure CBG Oil Wholesale variety that offers a new experience in the world of cannabis, as this is a genetic with an incredibly high percentage of CBG (12%) and one that is very low in THC, below 0.2%, making this cannabis legal almost everywhere in the world. This is a percentage of CBG Oil Wholesale that was previously difficult to achieve in commercial cannabis strains, a ratio limited to genetic laboratories that had managed to block some steps of the cannabinoid biosynthetic pathway, preventing the formation of tetrahydrocannabinol (THC) while increasing the accumulation of cannabigerol (CBG), which was previously found in residual amounts. In the case of our Pure CBG Oil Wholesale variety from Bona Voluntate, we have produced a fast-flowering plant - only 50 days - with a very Indica structural profile, with compact and highly branched plants that are very hardy, vigorous, and boast impressive yields of CBG-rich flowers, ushering in a new paradigm for both the medical community and cannabis growers looking for new sensations based on this cannabidiol.